Document is current
Any future updates will be listed below
-
Authors
Williams, Sarah E.
Noel, Maxence https://orcid.org/0000-0003-2621-7374
Lehoux, Sylvain
Cetinbas, Murat
Xavier, Ramnik J. https://orcid.org/0000-0002-5630-5167
Sadreyev, Ruslan I.
Scolnick, Edward M.
Smoller, Jordan W. https://orcid.org/0000-0002-0381-6334
Cummings, Richard D. https://orcid.org/0000-0002-8918-5034
Mealer, Robert G. https://orcid.org/0000-0001-5963-2836
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30DK040561, P41GM103694)
U.S. Department of Health & Human Services | National Institutes of Health
Broad Institute | Stanley Center for Psychiatric Research, Broad Institute
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (T32MH112485)
- License Information
-
More Information
Article History
Received: 15 April 2021
Accepted: 8 December 2021
First Online: 12 January 2022
Competing interests
: R.J.X. is a cofounder and equity holder of Celsius Therapeutics and Jnana Therapeutics and consultant to Novartis. These companies did not provide support for this work. J.W.S. is a member of the Scientific Advisory Board of Sensorium Therapeutics and has received honoraria for an internal seminar at Biogen, Inc and Tempus Labs. These companies did not provide support for this work. The remaining authors declare no competing interests.
